Patents by Inventor Douglas O. Spry

Douglas O. Spry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5393882
    Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.
    Type: Grant
    Filed: February 24, 1993
    Date of Patent: February 28, 1995
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
  • Patent number: 5239068
    Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.
    Type: Grant
    Filed: April 20, 1992
    Date of Patent: August 24, 1993
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
  • Patent number: 5142039
    Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.
    Type: Grant
    Filed: September 26, 1990
    Date of Patent: August 25, 1992
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
  • Patent number: 4983732
    Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with allyloxycarbonyl, t-butoxycarbonyl, naphthyloxycarbonyl, trichloroethyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzhydryloxycarbonyl, p-methoxybenzyloxycarbonyl, or o-nitrobenzyloxycarbonyl.
    Type: Grant
    Filed: September 21, 1989
    Date of Patent: January 8, 1991
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
  • Patent number: 4604386
    Abstract: 3-(alkynylalkyloxy)cephalosporin antibiotics and the intermediates therefor are disclosed. Pharmaceutical compositions for the antibiotics are also disclosed.
    Type: Grant
    Filed: July 9, 1984
    Date of Patent: August 5, 1986
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 4565655
    Abstract: Fused 4,7-.beta.-lactam bicyclic antibacterials, namely 8-acylamino-4-anilino-9-oxo-6-thia-1,3-diazabicyclo[5.2.0]non-3-ene-2-carb oxylic acids, and the esters, salts and sulfoxides thereof, are provided. The compounds as esters are prepared by process comprising heating a 3-azido-3-cephem ester with aniline, a substituted aniline, or an N-(C.sub.1 -C.sub.3 alkyl) derivative thereof.
    Type: Grant
    Filed: September 28, 1983
    Date of Patent: January 21, 1986
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 4560749
    Abstract: 3-Azido-3-cephem esters are reacted with electron rich olefins, e.g., enamines and cyclic enol ethers, to provide C.sub.3 amidines and imidates having antibacterial activity in the free acid form. For example, 3-azido-3-cephem esters react with ethyl vinyl ether to provide 3-[1-(ethoxyethylidene)amino]-3-cephem esters. The latter are deesterified to provide the free acid antibacterials.
    Type: Grant
    Filed: November 18, 1983
    Date of Patent: December 24, 1985
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 4533497
    Abstract: N-ethylidene azetidinones are new antibiotic compounds. They are produced from the reaction of a Grignard reagent with a cephalosporin substituted at the 3 position with a chloro, oxy, amino or sulfide moieties.
    Type: Grant
    Filed: December 27, 1982
    Date of Patent: August 6, 1985
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 4521598
    Abstract: 7.beta.-Acylamino-3-azido-3-cephem-4-carboxylic acid esters are obtained with the corresponding 3-halo or 3-sulfonyloxy-3-cephem esters and an alkali metal azide. The 3-azido compounds as the free acids or salts are antibacterial agents while in esterified form react with alcohols and phenols to provide 2-alkoxy (or 2-phenoxy)-3amino-3-cephem esters and isomeric ring expanded 4,7-bicyclo .beta.-lactam compounds, namely [2R-(2.alpha.,7.alpha.,8.beta.)-4-alkoxy (or 4-phenoxy)-9-oxo-8-acylamino-6-thia-1,3-diazabicyclo[5.2.0]non-3-ene-2-car boxylic acids and esters and the corresponding 3-alkoxy (or 3-phenoxy) 1,4-diazabicyclo[5.2.0]non-3-ene-2-carboxylic acids and esters. These reaction products obtained with the azide possess antibacterial properties.
    Type: Grant
    Filed: September 28, 1983
    Date of Patent: June 4, 1985
    Assignee: Eli Lilly and Company
    Inventors: Douglas O. Spry, Wayne A. Spitzer
  • Patent number: 4334063
    Abstract: 7-Acylamido-2-halomethylidene-3-methyl and 3-acetoxymethyl-3-cephem-4-carboxylic acids and esters are prepared via reaction of the corresponding 2-exomethylene-3-cephem ester sulfoxides with chloro (or bromo) dimethyliminium chlorides (or bromides). The 2-halomethylidene derivatives are useful as antimicrobial agents and intermediates to novel 2-acyloxymethylidene cephalosporins and to the known 2-aryl (or alkyl) mercaptomethylidene cephalosporins.
    Type: Grant
    Filed: March 30, 1981
    Date of Patent: June 8, 1982
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 4334064
    Abstract: 7-Acylamido-2-halomethylidene-3-methyl and 3-acetoxymethyl-3-cephem-4-carboxylic acids and esters are prepared via reaction of the corresponding 2-exomethylene-3-cephem ester sulfoxides with chloro (or bromo) dimethyliminium chlorides (or bromides). The 2-halomethylidene derivatives are useful as antimicrobial agents and intermediates to novel 2-acyloxy-methylidene cephalosporins and to the known 2-aryl (or alkyl) mercaptomethylidene cephalosporins.
    Type: Grant
    Filed: March 30, 1981
    Date of Patent: June 8, 1982
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 4299954
    Abstract: 7-Acylamino-2-halomethylidene-3-methyl and 3-acetoxymethyl-3-cephem-4-carboxylic acids and esters are prepared via reaction of the corresponding 2-exomethylene-3-cephem ester sulfoxides with chloro (or bromo) dimethyliminium chlorides (or bromides). The 2-halomethylidene derivatives are useful as antimicrobial agents and intermediates to novel 2-acyloxymethylidene cephalosporins and to the known 2-aryl (or alkyl) mercaptomethylidene cephalosporins.
    Type: Grant
    Filed: November 5, 1979
    Date of Patent: November 10, 1981
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 4133808
    Abstract: Ozonolysis of 3-bromomethyl-2-cephem-4-carboxylic acid esters provides 1-(1-protected carboxy-2-hydroxy-3-bromo-1-propenyl)-3-amido(or imido)-4-formylthio-azetidin-2-ones, useful as intermediates in the preparation of cephalosporin antibiotics.
    Type: Grant
    Filed: May 10, 1977
    Date of Patent: January 9, 1979
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Douglas O. Spry
  • Patent number: 4115643
    Abstract: 7-Acylamido-3-hydroxy-3-cephem-4-carboxylic acid ester sulfoxides are chlorinated and reduced in a single step process with phosphorus trichloride in dimethylformamide to provide 7-acylamido-3-chloro-3-cephem-4-carboxylic acid ester sulfides.
    Type: Grant
    Filed: August 8, 1977
    Date of Patent: September 19, 1978
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Douglas O. Spry
  • Patent number: 4048157
    Abstract: Ozonolysis of 3-bromomethyl-2-cephem-4-carboxylic acid esters provides 1-(1-protected carboxy-2-hydroxy-3-bromo-1-propenyl)-3-amido(or imido)-4-formylthio-azetidin-2-ones, useful as intermediates in the preparation of cephalosporin antibiotics.
    Type: Grant
    Filed: October 29, 1975
    Date of Patent: September 13, 1977
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Douglas O. Spry
  • Patent number: 4031084
    Abstract: 7-Acylamido-3-exomethylenecepham ester sulfoxides are reacted with ozone to provide the corresponding 3-hydroxy-3-cephem ester sulfoxides, intermediates for 3-methoxy and 3-halo substituted cephalosporin antibiotics; e.g., p-nitrobenzyl 7-phenoxyacetamido-3-exomethylenecepham-4-carboxylate-1-oxide provides the corresponding 3-hydroxy-3-cephem ester sulfoxide.
    Type: Grant
    Filed: October 23, 1975
    Date of Patent: June 21, 1977
    Assignee: Eli Lilly and Company
    Inventors: Stjepan Kukolja, Douglas O. Spry
  • Patent number: 4012380
    Abstract: Intermediate C-3 1-hydroxyalkyl or 1-hydroxyarylalkyl cephems, prepared by reacting Grignard reagents at low temperature with 3-formyl-2-cephem compounds, are oxidized to the corresponding 7-acylamino-3-acyl-2(or 3)cephem-4-carboxylic acids and esters thereof, which are useful as antibiotics or as intermediates in preparing antibiotic substances.
    Type: Grant
    Filed: December 10, 1974
    Date of Patent: March 15, 1977
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 4001226
    Abstract: 7-Acylamino and 7-amino-3-(substituted)carbonylamino-3(or 2)-cephem-4-carboxylic acids and esters thereof, which are useful as antibiotics or as intermediates in preparing antibiotic substances respectively, are prepared from 7-acylamino-3-azidocarbonyl-2(or 3)-cephem-4-carboxylic acid esters via the corresponding thermally derived 3-isocyanatocephem derivatives.
    Type: Grant
    Filed: December 4, 1974
    Date of Patent: January 4, 1977
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 3953436
    Abstract: 7-Acylamino and 7-amino-3-carboxy-3-cephem-4-carboxylic acids and derivatives thereof, which are useful as antibiotics or as intermediates in preparing antibiotic substances, are prepared by an NBS oxidation of acetal derivatives of 3-formyl cephalosporins.
    Type: Grant
    Filed: April 19, 1974
    Date of Patent: April 27, 1976
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry
  • Patent number: 3933806
    Abstract: 7-Acylamino-2-(substituted ethyl)-3-(substituted alkyl)-3-cephem-4-carboxylic acids and esters are prepared via carbanion addition to 2-methylene-3-cephem sulfoxides to provide antibiotic cephalosporin Michael adducts.
    Type: Grant
    Filed: July 17, 1973
    Date of Patent: January 20, 1976
    Assignee: Eli Lilly and Company
    Inventor: Douglas O. Spry